España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Theravance Biopharma
TBPH
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$9.91
-0.08
-0.80%
Last update: 2:13 PM
15 minutes delayed
Get Report
Comment
Theravance Biopharma (TBPH) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Theravance Biopharma (NASDAQ:TBPH) Stock
Theravance Biopharma Stock (NASDAQ: TBPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, June 12, 2024
Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Wednesday, May 29, 2024
HC Wainwright & Co. Reiterates Buy on Therava...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Buy on Therava...
Benzinga Newsdesk
Monday, May 13, 2024
Theravance Biopharma Q1 2024 GAAP EPS $(0.24)...
Benzinga Newsdesk
Friday, April 12, 2024
Theravance Biopharma shares are trading highe...
Benzinga Newsdesk
BTIG Initiates Coverage On Theravance Biophar...
Benzinga Newsdesk
Monday, February 26, 2024
Theravance Biopharma Expects Non-GAAP Loss In...
Benzinga Newsdesk
Recap: Theravance Biopharma Q4 Earnings
Benzinga Insights
Theravance Biopharma Q4 2023 GAAP EPS $(0.17)...
Benzinga Newsdesk
Earnings Scheduled For February 26, 2024
Benzinga Insights
Friday, February 23, 2024
A Preview Of Theravance Biopharma's Earnings
Benzinga Insights
Tuesday, January 23, 2024
Logitech Posts Q3 Results, Joins Coinbase And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
Tuesday, January 16, 2024
On January 12, 2024, Theravance Biopharma And Mylan Entered Into A Settlement Agreement With Orbicular Pharmaceutical Technologies Private Limited Regarding Yupelri Inhalation Solution
Charles Gross
Friday, January 05, 2024
Theravance Biopharma shares are trading lower...
Benzinga Newsdesk
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Why Is Lung Disease Focused Theravance Biopharma Stock Trading Lower Today?
Vandana Singh
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Theravance Biopharma Announces Results From P...
Benzinga Newsdesk
Thursday, December 28, 2023
Theravance Biopharma Said On Dec 26 Units, Mylan Ireland & Mylan Specialty Entered Settlement Agreement With Accord Healthcare Relating To Yupelri (Revefenacin) Inhalation Solution
Charles Gross
Thursday, November 16, 2023
Theravance Biopharma Will Present New Amprelo...
Benzinga Newsdesk
Monday, November 13, 2023
Viatris And Theravance Biopharma Announce Top...
Benzinga Newsdesk
Wednesday, November 08, 2023
Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday
Lisa Levin
Tuesday, November 07, 2023
Theravance Biopharma Q3 2023 GAAP EPS $(0.17)...
Benzinga Newsdesk
Earnings Scheduled For November 7, 2023
Benzinga Insights
Monday, October 30, 2023
Theravance Biopharma Said Co's Units, Mylan Ireland Limited & Mylan Specialty L.P. Entered Settlement Deal With Teva Pharmaceuticals, Its Units Regarding Patent Litigation
Charles Gross
Friday, September 29, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, September 28, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Friday, September 15, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, August 28, 2023
Theravance Biopharma to Present New Ampreloxe...
Benzinga Newsdesk
Tuesday, August 08, 2023
HC Wainwright & Co. Reiterates Buy on Therava...
Benzinga Newsdesk
Monday, August 07, 2023
UPDATE: Theravance Biopharma Q2 Adj EPS $(0.1...
Benzinga Newsdesk
Theravance Biopharma Q2 Adj $(0.13) Beats $(0...
Benzinga Newsdesk
Earnings Scheduled For August 7, 2023
Benzinga Insights
Friday, August 04, 2023
Theravance Biopharma Earnings Preview
Benzinga Insights
Thursday, May 11, 2023
Takeda Moves Out From Licensing Agreement With Theravance Biopharma
Vandana Singh
Tuesday, May 09, 2023
Theravance Says Orphan Drug Designation Grant...
Benzinga Newsdesk
Theravance Biopharma Ireland Limited Granted Orphan Designation Status For Ampreloxetine For The Treatment Of Symptomatic Neurogenic Orthostatic Hypotension In Patients With Multiple System Atrophy
Happy Mohamed
HC Wainwright & Co. Maintains Buy on Theravan...
Benzinga Newsdesk
Monday, May 08, 2023
Theravance Biopharma Q1 Adj EPS $(0.24) Beats...
Benzinga Newsdesk
Earnings Scheduled For May 8, 2023
Benzinga Insights
Wednesday, April 19, 2023
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
David Willey
-
Sponsored
Wednesday, April 12, 2023
Theravance Biopharma 13D Filing Reports Weiss Asset Management LP Reports 11.79% Stake In Co
Happy Mohamed
Tuesday, February 28, 2023
Theravance Biopharma Finally Shelves Failed JAK Inhibitor Program, Lays Off Staff
Vandana Singh
HC Wainwright & Co. Reiterates Buy on Therava...
Benzinga Newsdesk
UPDATE: Theravance Biopharma Q4 Adj. EPS $(0.21) Misses $(0.17) Estimate, Sales $14.65M Miss $15.73M Estimate
Happy Mohamed
Monday, February 27, 2023
Theravance Biopharma Q4 EPS $(0.21) Misses $(...
Benzinga Newsdesk
Theravance Biopharma Sees FY23 R&D Expense Of $35M-$45M And SG&A Expense Of $45M-$55M
Happy Mohamed
Irenic Sends Letter To Theravance Biopharma R...
Benzinga Newsdesk
Earnings Scheduled For February 27, 2023
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch